Acrivon Therapeutics, Inc. (ACRV) Insider Trading

Name: Acrivon Therapeutics, Inc. (ACRV) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Oct 7, 2026): Mary Miller (Chief Legal Officer): Sale of 294 shares, $585.06.

Get alerted when insiders trade ACRV

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta